Search For "serum institute"
Pune firm gears up to transport Covid-19 vaccines
Updated : 5 years, 4 months ago IST
Pune (Maharashtra) [India] January 11 (ANI): As India is all set to start the massive inoculation drive against the COVID-19 outbreak, the Pune-based logistic firm Kool-ex Cold Chain is prepared to transport the vaccine vials from Serum Institute of India to other parts of the country. Read More
Serum Institute receives GoI's order for 11 million vaccine doses
Updated : 5 years, 4 months ago IST
New Delhi [India], January 11 (ANI): Serum Institute of India (SII) has received the purchase order from the Government of India and 11 million doses of vaccine, Covishield would be available at the price of Rs 200 per vial, said insiders at the SII on Monday.
Read More
Ecuador envoy takes part in Covaxin trials, says Indian vaccines safe, con
Updated : 5 years, 4 months ago IST
New Delhi [India], January 8 (ANI): After taking the first shot of Covaxin, Ecuador's Envoy to India Hector Cueva Jacome on Friday said that Bharat Biotech and Serum Institute are good companies, adding that he talked to researchers in US and Ecuador and then took part in the trials.
Read More
Maharashtra firm moves Pune court against Serum Institute over 'Covishield
Updated : 5 years, 4 months ago IST
Pune (Maharashtra) [India], January 7 (ANI): A biotech firm based in Nanded, Maharashtra, has filed a suit against Serum Institute of India at a commercial court in Pune for using the trademark 'Covishield' for COVID-19 vaccine being manufactured by it.
Read More
SII, Bharat Biotech jointly pledge 'smooth rollout' of COVID-19 vaccines
Updated : 5 years, 4 months ago IST
Pune/Hyderabad [India], January 5 (ANI): Serum Institute of India and Bharat Biotech jointly communicated their pledge on Tuesday for the smooth rollout of COVID-19 vaccines to India and the world.
Read More
Second dose of Covishield should be administered between four to six weeks
Updated : 5 years, 4 months ago IST
New Delhi [India], January 4 (ANI): In its permission to Serum Institute of India for "manufacture for sale or distribution" of COVID-19 vaccine 'Covishield', the DGCI has said that the second dose should be administered between four to six weeks after the first dose and also noted that the
Read More
CM Chouhan says will not get vaccinated now, focus should be on priority g
Updated : 5 years, 4 months ago IST
Bhopal (Madhya Pradesh) [India], January 4 (ANI): As India gears up for the world's largest vaccination programme, Madhya Pradesh Chief Minister Shivraj Singh Chouhan on Monday said he will take the coronavirus vaccine later as he wants priority groups to get the jab first.
Read More
COVAXIN's approval is for emergency situation, not emergency use authorisa
Updated : 5 years, 4 months ago IST
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
Read More
Afghanistan hails emergency use approval to Covishield
Updated : 5 years, 4 months ago IST
New Delhi [India], January 3 (ANI): Tahir Qadiry, Afghan Charge d'Affaires on Sunday hailed India's decision to grant emergency use to Serum Institute of India for their Covid-19 vaccine, named Covishield.
Read More
SII CEO says safe, effective COVID-19 vaccine ready for roll-out
Updated : 5 years, 4 months ago IST
New Delhi [India], January 3 (ANI): Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said Serum Institute of India Chief Executive Officer Adar Poonawalla on Sunday.
Read More
PM Modi congratulates nation, scientists after emergency use approval to C
Updated : 5 years, 4 months ago IST
New Delhi [India], January 3 (ANI): Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines on Sunday.
Read More
DCGI to brief media today on COVID-19 vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
Read More